Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 30/3/2020
SIETES contiene 92954 citas

<< anterior 21 a 40 de 1328 siguiente >>
Presentar resultados
Seleccionar todas
22. Cita con resumen
Chanq Z, Quinn PD, Hur K, Gibbons RD, Sjolander A, Larsson H, D'Onofrio BM. Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry 2017;74:597-603. [Ref.ID 101569]
23. Cita con resumen
Anónimo. Pitolisant for narcolepsy. Drug Ther Bull 2017;55:6-8. [Ref.ID 101353]
24. Cita con resumen
Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 2016;315:2424-34. [Ref.ID 100458]
25.Enlace a cita original Cita con resumen
Hoshen MB, Benis A, Keyes KM, Zoëga H. Stimulant use for ADHD and relative age in class among children in Israel. Pharmacoepidemiol Drug Saf 2016;25:652-60. [Ref.ID 100395]
26. Cita con resumen
Jackson JW. The cardiovascular safety of methylphenidate. BMJ 2016;353:i2874. [Ref.ID 100356]
28. Cita con resumen
30. Cita con resumen
Anonimo. FDA approves chewable version of AD/HD stimulant medication. DIA Daily 2015:1. [Ref.ID 99726]
31.Tiene citas relacionadas Cita con resumen
Storebo OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Homskov M, Skoog M, Nilausen TD, Magnusson FL, Zwi M, Gillies D, Rosendal S, Groth C, Rasmussen KB, Gauci D, Kirubakaran R, Forsbol B, Simonsen E, Gluud C. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ 2015;351:h5203. [Ref.ID 99705]
32. Cita con resumen
Hawkes N. Sixty seconds on . . . ADHD. BMJ 2015;351:h6294. [Ref.ID 99703]
33.Tiene citas relacionadas Cita con resumen
Fazel M. Methylphenidate for ADHD. BMJ 2015;351:h5875. [Ref.ID 99702]
34. Cita con resumen
Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics 2015;136:1144-53. [Ref.ID 99685]
36. Cita con resumen
Anónimo. Teva Pharmaceuticals settles FTC’s claim against Cephalon for $1.2 billion. DIA Daily 2015:29 de mayo. [Ref.ID 99107]
37. Cita con resumen
Cunill R, Castells X. Trastorno por déficit de atención con hiperactividad. Med Clin (Barc) 2015;144:370-5. [Ref.ID 98996]
38. Cita con resumen
Loymans RJB, Gemperli A, Cohen J, Rubinstein SM, Sterk PJ, Reddel HK, Jüni P, Ter Riet G. Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ 2014;348:g3009. [Ref.ID 98004]
39. Cita con resumen
Hampton T. FDA alert on pure caffeine powder. JAMA 2014;312:779. [Ref.ID 97897]
40. Cita con resumen
Anónimo. Shire touts business prospects in attempt to thwart AbbVie’s bid. DIA Daily 2014:24 de junio. [Ref.ID 97712]
Seleccionar todas
<< anterior 21 a 40 de 1328 siguiente >>